Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharad Kumar Suthar

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Mini Reviews in Medicinal Chemistry|April 29, 2016
Recent Developments in Chimeric NSAIDs as Anticancer Agents: Teaching an Old Dog a New TrickSharad Kumar Suthar, Manu Sharma
Medicinal Research Reviews|October 17, 2014
Recent developments in chimeric NSAIDs as safer anti-inflammatory agentsSharad Kumar Suthar, Manu Sharma
Frontiers in Molecular Neuroscience|December 16, 2022
Ingenuity pathway analysis of <i>α</i>-synuclein predicts potential signaling pathways, network molecules, biological functions, and its role in neurological diseasesSharad Kumar Suthar, Sang-Yoon Lee
Brain Sciences|January 21, 2023
The Role of Superoxide Dismutase 1 in Amyotrophic Lateral Sclerosis: Identification of Signaling Pathways, Regulators, Molecular Interaction Networks, and Biological Functions through BioinformaticsSharad Kumar Suthar, Sang-Yoon Lee
European Journal of Medicinal Chemistry|January 25, 2014
Novel lung adenocarcinoma and nuclear factor-kappa B (NF-κB) inhibitors: synthesis and evaluation of lantadene congenersSharad Kumar Suthar, Hong L Boon, Manu Sharma
Journal of Biomolecular Structure & Dynamics|December 5, 2024
Synthesis, biological evaluation, and <i>in silico</i> studies of lantadene-derived pentacyclic triterpenoids as anticancer agents targeting IKK-βSharad Kumar Suthar, Jitender Monga, Manu Sharma, et al.
Food & Function|October 14, 2014
Topical (+)-catechin emulsified gel prevents DMBA/TPA-induced squamous cell carcinoma of the skin by modulating antioxidants and inflammatory biomarkers in BALB/c miceJitender Monga, Vaibhav Aggarwal, Sharad Kumar Suthar, et al.
Current Topics in Medicinal Chemistry|March 26, 2014
Novel dual inhibitors of nuclear factor-kappa B (NF-κB) and cyclooxygenase- 2 (COX-2): synthesis, in vitro anticancer activity and stability studies of lantadene-non steroidal anti-inflammatory drug (NSAID) conjugatesSharad Kumar Suthar, Neetika Sharma, Hong Boon Lee, et al.
European Journal of Medicinal Chemistry|July 6, 2013
Design and synthesis of novel 4-(4-oxo-2-arylthiazolidin-3-yl)benzenesulfonamides as selective inhibitors of carbonic anhydrase IX over I and II with potential anticancer activitySharad Kumar Suthar, Sumit Bansal, Sandeep Lohan, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2014
Synthesis of lantadene analogs with marked in vitro inhibition of lung adenocarcinoma and TNF-α induced nuclear factor-kappa B (NF-κB) activationMonika, Ankesh Sharma, Sharad Kumar Suthar, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Mini Reviews in Medicinal Chemistry|April 29, 2016
Recent Developments in Chimeric NSAIDs as Anticancer Agents: Teaching an Old Dog a New TrickSharad Kumar Suthar, Manu Sharma
Medicinal Research Reviews|October 17, 2014
Recent developments in chimeric NSAIDs as safer anti-inflammatory agentsSharad Kumar Suthar, Manu Sharma
Frontiers in Molecular Neuroscience|December 16, 2022
Ingenuity pathway analysis of <i>α</i>-synuclein predicts potential signaling pathways, network molecules, biological functions, and its role in neurological diseasesSharad Kumar Suthar, Sang-Yoon Lee
Brain Sciences|January 21, 2023
The Role of Superoxide Dismutase 1 in Amyotrophic Lateral Sclerosis: Identification of Signaling Pathways, Regulators, Molecular Interaction Networks, and Biological Functions through BioinformaticsSharad Kumar Suthar, Sang-Yoon Lee
European Journal of Medicinal Chemistry|January 25, 2014
Novel lung adenocarcinoma and nuclear factor-kappa B (NF-κB) inhibitors: synthesis and evaluation of lantadene congenersSharad Kumar Suthar, Hong L Boon, Manu Sharma
Journal of Biomolecular Structure & Dynamics|December 5, 2024
Synthesis, biological evaluation, and <i>in silico</i> studies of lantadene-derived pentacyclic triterpenoids as anticancer agents targeting IKK-βSharad Kumar Suthar, Jitender Monga, Manu Sharma, et al.
Food & Function|October 14, 2014
Topical (+)-catechin emulsified gel prevents DMBA/TPA-induced squamous cell carcinoma of the skin by modulating antioxidants and inflammatory biomarkers in BALB/c miceJitender Monga, Vaibhav Aggarwal, Sharad Kumar Suthar, et al.
Current Topics in Medicinal Chemistry|March 26, 2014
Novel dual inhibitors of nuclear factor-kappa B (NF-κB) and cyclooxygenase- 2 (COX-2): synthesis, in vitro anticancer activity and stability studies of lantadene-non steroidal anti-inflammatory drug (NSAID) conjugatesSharad Kumar Suthar, Neetika Sharma, Hong Boon Lee, et al.
European Journal of Medicinal Chemistry|July 6, 2013
Design and synthesis of novel 4-(4-oxo-2-arylthiazolidin-3-yl)benzenesulfonamides as selective inhibitors of carbonic anhydrase IX over I and II with potential anticancer activitySharad Kumar Suthar, Sumit Bansal, Sandeep Lohan, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2014
Synthesis of lantadene analogs with marked in vitro inhibition of lung adenocarcinoma and TNF-α induced nuclear factor-kappa B (NF-κB) activationMonika, Ankesh Sharma, Sharad Kumar Suthar, et al.
Pageof 3